3 days popular7 days popular1 month popular3 months popular

How to detect a moving target: infectious influenza virus in clinical specimens

Since their introduction in the human population in 1968, influenza A viruses of the H3 subtype have evolved continuously to escape recognition and neutralization by antibodies, a component of our immune system. These changes have also reduced the ability of viruses to bind red blood cells, termed hemagglutination, a trait that is widely utilized in laboratories to measure levels of infectious in .

Viroclinics Biosciences found a way to detect such by targeting a more conserved part of the virus that is present in all strains tested since 1934 to date. The rise of missed by hemagglutination-based techniques was documented for the period between 1999 and 2012, in close collaboration with Erasmus MC Viroscience department scientists. These results and the validity of the new method for quantitating infectious virus in clinical specimens is now reported in .

The new method requires no additional patient material and forms a prime asset for studies on the effectiveness of novel antiviral treatments against moving targets such as influenza A viruses.

Article: Detection of Nonhemagglutinating Influenza A(H3) Viruses by Enzyme-Linked Immunosorbent Assay in Quantitative Influenza Virus Culture, C. A. van Baalen, C. Elsa, L. Sprong, R. van Beek, E. van der Vries, A. D. M. E. Osterhausa, and G. F. Rimmelzwaana, Journal of Clinical Microbiology, DOI: 10.1128/JCM.03575-13, published online 12 March 2014.


Viroclinics Biosciences BV (Viroclinics)